On April 2, 2023, the first “Juyitang Pharmaceutical Industry Development Research Forum” hosted by Xianju Pharmaceutical Sales was successfully held in Hangzhou. More than 150 experts, scholars and entrepreneurs from the pharmaceutical industry gathered on the banks of the glittering Qiantang River to discuss the theme of “Innovation and Sustainable Development of the Pharmaceutical Industry under the Background of New Policies”.
- The forum opened with an address by Zhang Yusong, Chairman of Zhejiang Xianju Pharmaceutical Co., Ltd., and was hosted throughout by Zou Wenhui, General Manager of the Sales Company. Distinguished experts and scholars were invited to deliver in-depth interpretations of the opportunities and challenges facing the industry under the current policy and market environment, from three dimensions: policy implementation, pharmacy administration, and cutting-edge clinical information on steroid drugs. The invited guests included:
- Professor Xu Wei, Professor of China Pharmaceutical University and Vice Dean of the International School of Pharmaceutical Business
- Professor Shao Hua, Director of the Pharmacy Department, the Affiliated Zhongda Hospital of Southeast University
- Professor Zhou Quan, Deputy Director of the Pharmacy Department, the Second Affiliated Hospital of Zhejiang University School of Medicine
- Professor Xu Donghang, Executive Deputy Director of the Pharmacy Department, the Second Affiliated Hospital of Zhejiang University School of Medicine
- Professor Li Hua, Director of the Nephrology Department, Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine
- Professor Ma Kunling, Director of the Nephrology Department, the Second Affiliated Hospital of Zhejiang University School of Medicine
- “Juyitang” is designed to build an all-round, multi-level and high-standard platform for industry dialogue and cooperation. Through in-depth interpretations by experts from government, industry, academia and research sectors, and full exchanges among industrial representatives, it aims to spark ideological collisions and broaden horizons. The forum will help enterprises better understand policy planning and management priorities, improve the management methods and institutional standards for all links of drug R&D, launch, market access and circulation, innovate cooperation models, explore development paths together, provide new ideas, and ultimately achieve win-win results for all parties.
